LymeX Authorization Act

Bill: 117-hr-3637
Sponsor: full_name: Rep. Smith, Christopher H. [R-NJ-4]
Introduced: 2021-05-28
Policy area: Health
Subjects: Health programs administration and funding

Health promotion and preventive care

Infectious and parasitic diseases

Medical research

Medical tests and diagnostic methods

Research administration and funding
Latest action: action_date: 2021-05-31
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2021-05-28
action_desc: Introduced in House
text: <p><strong>LymeX Authorization Act</strong></p> <p>This bill authorizes the Department of Health and Human Services to carry out prize competitions to accelerate innovation in the prevention, diagnosis, and treatment of Lyme disease. Lyme disease is a bacterial infection carried by ticks that can spread to joints, the heart, and the nervous system.</p>

tv_txt: I 117th CONGRESS 1st Session H. R. 3637 IN THE HOUSE OF REPRESENTATIVES May 28, 2021 Mr. Smith of New Jersey (for himself, Mr. Cuellar , Mr. Gottheimer , Mr. Fitzpatrick , and Mr. Posey ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To authorize the Secretary of Health and Human Services to fund prize competitions to accelerate innovation in the prevention, diagnosis, and treatment of Lyme disease, and for other purposes.

1. Short title This Act may be cited as the LymeX Authorization Act . 2. Policy It is the policy of the United States to— (1) engage stakeholders, including academia, nonprofits, industry, small business, entrepreneurs, and government to facilitate patient-centered innovations in Lyme disease care; (2) foster breakthroughs in health education and public awareness initiatives focused on Lyme disease patients; and (3) accelerate development of next-gen diagnostics that are rapid and patient focused. 3. Authorization of appropriations There is authorized to be appropriated to the Secretary of Health and Human Services $5,000,000 to carry out prize competitions (as defined in section 24 of the Stevenson-Wydler Technology Innovation Act of 1980 ( 15 U.S.C. 3719 )) to accelerate innovation in the prevention, diagnosis, and treatment of Lyme disease.